{"success":true,"data":{"pressRelease":{"id":"135733","rtpr_id":"nBw7LcwGSa","ticker":"RVP","exchange":"NYSE American","all_tickers":["RVP"],"title":"Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act","author":"Business Wire","published_at":"2026-09-03T21:25:00.089Z","article_body":"Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE\nManufacturing Act\n\nRetractable Technologies, Inc. (“Retractable”) (NYSE American: RVP)\nannounces its support for Senator Marsha Blackburn’s ONSHORE Manufacturing\nAct, legislation aimed at strengthening domestic production of critical\nmedical supplies.\n\nThe legislation would provide tax incentives for U.S. manufacturing, including\ninvestments in advanced manufacturing equipment and facility modernization.\n\n“The ONSHORE Manufacturing Act is the spark American manufacturers need to\nrebuild our domestic medical base. This legislation ensures that healthcare\nproviders have uninterrupted access to safe, American-made medical products.\nWe are proud to support Senator Blackburn’s efforts in safeguarding our\npublic health infrastructure,” said Sarah Umandap, Government and Public\nAffairs department of Retractable Technologies, Inc.\n\nRetractable Technologies has manufactured medical devices in Little Elm, Texas\nfor decades while maintaining a global supply chain to support its product\nportfolio. The Company continues to invest in its domestic manufacturing\ncapabilities while ensuring reliable access to critical medical products.\n\nRetractable Technologies, Inc. looks forward to continuing to work with\npolicymakers on efforts that strengthen American manufacturing and improve the\nresilience of the nation’s medical supply chain.\n\nAccess Senator Blackburn’s press release here:\nhttps://www.blackburn.senate.gov/2026/7/blackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies?utm_source=chatgpt.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.blackburn.senate.gov%2F2026%2F7%2Fblackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies%3Futm_source%3Dchatgpt.com&esheet=54598708&newsitemid=20260903058820&lan=en-US&anchor=https%3A%2F%2Fwww.blackburn.senate.gov%2F2026%2F7%2Fblackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies%3Futm_source%3Dchatgpt.com&index=1&md5=3f20fa2f0e11db7be6fa936a5b557beb)\n\nFor more information on Retractable, visit its website at www.retractable.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fretractable.com%2F&esheet=54598708&newsitemid=20260903058820&lan=en-US&anchor=www.retractable.com&index=2&md5=ef1511e69f8ce0fdd23b7d05bd8a8bc8)\n.\n\nForward-looking statements in this press release are made pursuant to the safe\nharbor provision of the Private Securities Litigation Reform Act of 1995 and\nreflect Retractable's current views with respect to future events. Retractable\nbelieves that the expectations reflected in such forward-looking statements\nare accurate. However, Retractable cannot assure you that such expectations\nwill materialize. Actual future performance could differ materially from such\nstatements.\n\nFactors that could cause or contribute to such differences include, but are\nnot limited to: tariffs; oil prices; material changes in demand; Retractable's\nability to maintain liquidity; Retractable's maintenance of patent protection;\nRetractable's ability to maintain favorable third party manufacturing and\nsupplier arrangements and relationships; foreign trade risk; Retractable's\nability to access the market; production costs; the impact of larger market\nplayers in providing devices to the safety market; and other risks and\nuncertainties that are detailed from time to time in Retractable's periodic\nreports filed with the U.S. Securities and Exchange Commission.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260903058820/en/\n(https://www.businesswire.com/news/home/20260903058820/en/)\n\nFor further information regarding this release, please contact:\n\nSarah Umandap\n\nSenior Manager of Government & Public Affairs\n\nRetractable Technologies, Inc.\n\n412-482-7515 or 972-294-1010\n\nsarah.Umandap@retractable.com (mailto:sarah.Umandap@retractable.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw7LcwGSa","title":"Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE Manufacturing Act","author":"Business Wire","ticker":"RVP","created":"2026-09-03T21:25:00.089Z","tickers":["RVP"],"exchange":"NYSE American","article_body":"Retractable Technologies, Inc. Supports Senator Blackburn’s ONSHORE\nManufacturing Act\n\nRetractable Technologies, Inc. (“Retractable”) (NYSE American: RVP)\nannounces its support for Senator Marsha Blackburn’s ONSHORE Manufacturing\nAct, legislation aimed at strengthening domestic production of critical\nmedical supplies.\n\nThe legislation would provide tax incentives for U.S. manufacturing, including\ninvestments in advanced manufacturing equipment and facility modernization.\n\n“The ONSHORE Manufacturing Act is the spark American manufacturers need to\nrebuild our domestic medical base. This legislation ensures that healthcare\nproviders have uninterrupted access to safe, American-made medical products.\nWe are proud to support Senator Blackburn’s efforts in safeguarding our\npublic health infrastructure,” said Sarah Umandap, Government and Public\nAffairs department of Retractable Technologies, Inc.\n\nRetractable Technologies has manufactured medical devices in Little Elm, Texas\nfor decades while maintaining a global supply chain to support its product\nportfolio. The Company continues to invest in its domestic manufacturing\ncapabilities while ensuring reliable access to critical medical products.\n\nRetractable Technologies, Inc. looks forward to continuing to work with\npolicymakers on efforts that strengthen American manufacturing and improve the\nresilience of the nation’s medical supply chain.\n\nAccess Senator Blackburn’s press release here:\nhttps://www.blackburn.senate.gov/2026/7/blackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies?utm_source=chatgpt.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.blackburn.senate.gov%2F2026%2F7%2Fblackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies%3Futm_source%3Dchatgpt.com&esheet=54598708&newsitemid=20260903058820&lan=en-US&anchor=https%3A%2F%2Fwww.blackburn.senate.gov%2F2026%2F7%2Fblackburn-introduces-legislation-to-increase-domestic-production-of-critical-medical-supplies%3Futm_source%3Dchatgpt.com&index=1&md5=3f20fa2f0e11db7be6fa936a5b557beb)\n\nFor more information on Retractable, visit its website at www.retractable.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fretractable.com%2F&esheet=54598708&newsitemid=20260903058820&lan=en-US&anchor=www.retractable.com&index=2&md5=ef1511e69f8ce0fdd23b7d05bd8a8bc8)\n.\n\nForward-looking statements in this press release are made pursuant to the safe\nharbor provision of the Private Securities Litigation Reform Act of 1995 and\nreflect Retractable's current views with respect to future events. Retractable\nbelieves that the expectations reflected in such forward-looking statements\nare accurate. However, Retractable cannot assure you that such expectations\nwill materialize. Actual future performance could differ materially from such\nstatements.\n\nFactors that could cause or contribute to such differences include, but are\nnot limited to: tariffs; oil prices; material changes in demand; Retractable's\nability to maintain liquidity; Retractable's maintenance of patent protection;\nRetractable's ability to maintain favorable third party manufacturing and\nsupplier arrangements and relationships; foreign trade risk; Retractable's\nability to access the market; production costs; the impact of larger market\nplayers in providing devices to the safety market; and other risks and\nuncertainties that are detailed from time to time in Retractable's periodic\nreports filed with the U.S. Securities and Exchange Commission.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260903058820/en/\n(https://www.businesswire.com/news/home/20260903058820/en/)\n\nFor further information regarding this release, please contact:\n\nSarah Umandap\n\nSenior Manager of Government & Public Affairs\n\nRetractable Technologies, Inc.\n\n412-482-7515 or 972-294-1010\n\nsarah.Umandap@retractable.com (mailto:sarah.Umandap@retractable.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-09-03T21:25:00.138490256Z","server_sent_at_ms":1788470700138},"received_at":"2026-09-03T21:25:00.198Z","source_url":"https://www.businesswire.com/news/home/20260903058820/en/"},"analysis":{"id":"124612","press_release_id":"135733","analysis_json":{"industry":{"label":"Health Care Equipment & Supplies","sector":"Health Care"},"redFlags":["Legislation is proposed, not enacted — any tax-incentive benefit to RVP is speculative with an uncertain timeline","Release contains no quantitative guidance or financial impact estimates"],"eventType":"regulatory","narrative":"Retractable Technologies (NYSE American: RVP) publicly endorsed Senator Marsha Blackburn's ONSHORE Manufacturing Act, legislation intended to strengthen U.S. production of critical medical supplies.\n\nThe bill would provide tax incentives for U.S. manufacturing, including investments in advanced manufacturing equipment and facility modernization — incentives that would align with RVP's Texas-based production footprint.\n\nRVP has manufactured medical devices in Little Elm, Texas for decades and says it continues to invest in domestic capacity; the release is an advocacy statement with no financial figures or immediate impact disclosed.","sentiment":"bullish","agentHooks":{"shouldPost":false,"suggestedAngle":"Domestic manufacturer RVP backs the ONSHORE Manufacturing Act — prospective tax incentives for U.S. medical-device production only if the bill advances."},"keyFigures":{},"quotedText":"uninterrupted access to safe, American-made medical products","namedEntities":{"people":[{"name":"Marsha Blackburn","role":"U.S. Senator, sponsor of the ONSHORE Manufacturing Act"},{"name":"Sarah Umandap","role":"Senior Manager of Government & Public Affairs, Retractable Technologies, Inc."}],"products":[],"companies":[{"name":"Retractable Technologies, Inc.","ticker":"RVP","relationship":"filer; domestic manufacturer endorsing the legislation"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"This is an issuer-authored endorsement of proposed legislation (the ONSHORE Manufacturing Act), not an enacted law. If passed, tax incentives for U.S. manufacturing equipment and facility modernization would directly favor RVP as a domestic medical-device producer, but there is no immediate financial effect and no figures disclosed."},"tickerRelevance":{"others":[],"primary":"RVP"},"globalImportance":15,"audienceRelevance":12,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"legislative-endorsement","enactmentRisk":"high","issuerAuthored":true,"financialFiguresDisclosed":false}},"event_type":"regulatory","event_type_secondary":null,"sentiment":"bullish","material_impact_score":2,"narrative":"Retractable Technologies (NYSE American: RVP) publicly endorsed Senator Marsha Blackburn's ONSHORE Manufacturing Act, legislation intended to strengthen U.S. production of critical medical supplies.\n\nThe bill would provide tax incentives for U.S. manufacturing, including investments in advanced manufacturing equipment and facility modernization — incentives that would align with RVP's Texas-based production footprint.\n\nRVP has manufactured medical devices in Little Elm, Texas for decades and says it continues to invest in domestic capacity; the release is an advocacy statement with no financial figures or immediate impact disclosed.","key_figures":{},"named_entities":{"people":[{"name":"Marsha Blackburn","role":"U.S. Senator, sponsor of the ONSHORE Manufacturing Act"},{"name":"Sarah Umandap","role":"Senior Manager of Government & Public Affairs, Retractable Technologies, Inc."}],"products":[],"companies":[{"name":"Retractable Technologies, Inc.","ticker":"RVP","relationship":"filer; domestic manufacturer endorsing the legislation"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-03T21:25:59.940Z","global_importance":15,"audience_relevance":12,"importance_components":{"tickerTier":"micro-cap","eventGravity":"legislative-endorsement","enactmentRisk":"high","issuerAuthored":true,"financialFiguresDisclosed":false}},"durationMs":59727,"modelName":"glm-4.7"}}